Caitong International Asset Management Co., LTD Adma Biologics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 2,983 shares of ADMA stock, worth $47,429. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,983
Previous 2,983
-0.0%
Holding current value
$47,429
Previous $51.2 Million
-0.0%
% of portfolio
0.05%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
334Shares Held
188MCall Options Held
1.52MPut Options Held
756K-
Black Rock Inc. New York, NY18.6MShares$296 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$289 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$236 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$180 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$88 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.12B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...